None listed
Conditions
Interventions
Others(korean medicine clinical pathway for persistent Postural-perceptual dizziness) : Subjects can choose between korean medicine clinical pathway (CP)-applied treatment and conventional korean medi
Sponsors
Dong-Eui University Oriental Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult male or female aged 19 or older and under 65 years old 2. Patients who are diagnosed with Persistent Postural-Perceptual Dizziness below and complain of dizziness with a DHI score of 16 or higher or an NRS score of 4 or higher - Persistent non-rotational dizziness for more than 3 months - Hypersensitivity to one's own movement or movement of the surrounding environment for more than 3 months - Symptoms worsen in a complex visual environment or when precise visual tasks such as reading or using a computer are required 3. Those who have agreed by signing the written consent form provided
Exclusion criteria
Exclusion criteria: 1. Those diagnosed with dizziness due to cardiovascular disease (arrhythmia, heart valve disease, anemia, orthostatic hypotension, coronary artery disease, etc.) 2. Those diagnosed with dizziness due to active or uncontrolled diseases (e.g., uncontrolled diabetes, hypertension, other respiratory and endocrine diseases) 3. Those diagnosed with dizziness due to medication currently being taken 4. Those diagnosed with serious chronic or terminal diseases (malignant tumor, chronic renal failure, tuberculosis, etc.) 5. Patients complaining of dizziness associated with cervical movement or cervical posture accompanied by neck pain or stiffness 6. Those diagnosed with abnormalities through neurological examinations and brain imaging tests 7. Those who have received other treatment (non-steroidal anti-inflammatory drugs, steroids, etc.) due to dizziness caused by vestibular dysfunction within the past month 8. Those who are pregnant, plan to become pregnant during the trial period, or are breastfeeding 9. Those suspected of alcohol or drug abuse 10. Those who have participated in another clinical trial within 1 month of the start date of the intervention 11. Those with communication disorders that make it difficult to follow the investigator's instructions 12. Those who are judged unsuitable for trial participation by the principal investigator or investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Dizziness Handicap Inventory (DHI): Difference in score after 4 weeks (V9) compared to baseline (V2) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in the Numeric Rating Scale (NRS): Difference in scores each week (V3-9) compared to baseline (V2);Change in quality of life assessment tool(EQ-5D-5L): V9 score difference compared to V2;Patient Satisfaction Survey;Adverse Events | — |
Countries
Korea, Republic of
Contacts
Public Contactsoohyung jeon
Dong-Eui University Oriental Medicine Hospital
Outcome results
None listed